335 related articles for article (PubMed ID: 20188075)
1. Mapping the CGRP receptor ligand binding domain: tryptophan-84 of RAMP1 is critical for agonist and antagonist binding.
Moore EL; Gingell JJ; Kane SA; Hay DL; Salvatore CA
Biochem Biophys Res Commun; 2010 Mar; 394(1):141-5. PubMed ID: 20188075
[TBL] [Abstract][Full Text] [Related]
2. Non-peptidic antagonists of the CGRP receptor, BIBN4096BS and MK-0974, interact with the calcitonin receptor-like receptor via methionine-42 and RAMP1 via tryptophan-74.
Miller PS; Barwell J; Poyner DR; Wigglesworth MJ; Garland SL; Donnelly D
Biochem Biophys Res Commun; 2010 Jan; 391(1):437-42. PubMed ID: 19914210
[TBL] [Abstract][Full Text] [Related]
3. Crystal structure of the ectodomain complex of the CGRP receptor, a class-B GPCR, reveals the site of drug antagonism.
ter Haar E; Koth CM; Abdul-Manan N; Swenson L; Coll JT; Lippke JA; Lepre CA; Garcia-Guzman M; Moore JM
Structure; 2010 Sep; 18(9):1083-93. PubMed ID: 20826335
[TBL] [Abstract][Full Text] [Related]
4. Identification and pharmacological characterization of domains involved in binding of CGRP receptor antagonists to the calcitonin-like receptor.
Salvatore CA; Mallee JJ; Bell IM; Zartman CB; Williams TM; Koblan KS; Kane SA
Biochemistry; 2006 Feb; 45(6):1881-7. PubMed ID: 16460034
[TBL] [Abstract][Full Text] [Related]
5. Refolding and characterization of a soluble ectodomain complex of the calcitonin gene-related peptide receptor.
Koth CM; Abdul-Manan N; Lepre CA; Connolly PJ; Yoo S; Mohanty AK; Lippke JA; Zwahlen J; Coll JT; Doran JD; Garcia-Guzman M; Moore JM
Biochemistry; 2010 Mar; 49(9):1862-72. PubMed ID: 20099900
[TBL] [Abstract][Full Text] [Related]
6. Binding and functional pharmacological characteristics of gepant-type antagonists in rat brain and mesenteric arteries.
Sheykhzade M; Amandi N; Pla MV; Abdolalizadeh B; Sams A; Warfvinge K; Edvinsson L; Pickering DS
Vascul Pharmacol; 2017 Mar; 90():36-43. PubMed ID: 28192258
[TBL] [Abstract][Full Text] [Related]
7. Crystal structure of the human receptor activity-modifying protein 1 extracellular domain.
Kusano S; Kukimoto-Niino M; Akasaka R; Toyama M; Terada T; Shirouzu M; Shindo T; Yokoyama S
Protein Sci; 2008 Nov; 17(11):1907-14. PubMed ID: 18725456
[TBL] [Abstract][Full Text] [Related]
8. Structure-function analysis of RAMP1 by alanine mutagenesis.
Simms J; Hay DL; Bailey RJ; Konycheva G; Bailey G; Wheatley M; Poyner DR
Biochemistry; 2009 Jan; 48(1):198-205. PubMed ID: 19072332
[TBL] [Abstract][Full Text] [Related]
9. Activation of calcitonin receptor and calcitonin receptor-like receptor by membrane-anchored ligands.
Chang CL; Park JI; Hsu SY
J Biol Chem; 2010 Jan; 285(2):1075-80. PubMed ID: 19903822
[TBL] [Abstract][Full Text] [Related]
10. Mapping interaction sites within the N-terminus of the calcitonin gene-related peptide receptor; the role of residues 23-60 of the calcitonin receptor-like receptor.
Barwell J; Miller PS; Donnelly D; Poyner DR
Peptides; 2010 Jan; 31(1):170-6. PubMed ID: 19913063
[TBL] [Abstract][Full Text] [Related]
11. Sensitization of calcitonin gene-related peptide receptors by receptor activity-modifying protein-1 in the trigeminal ganglion.
Zhang Z; Winborn CS; Marquez de Prado B; Russo AF
J Neurosci; 2007 Mar; 27(10):2693-703. PubMed ID: 17344407
[TBL] [Abstract][Full Text] [Related]
12. Structure-function analysis of RAMP1-RAMP3 chimeras.
Qi T; Simms J; Bailey RJ; Wheatley M; Rathbone DL; Hay DL; Poyner DR
Biochemistry; 2010 Jan; 49(3):522-31. PubMed ID: 20017504
[TBL] [Abstract][Full Text] [Related]
13. Calcitonin receptor-like receptor (CLR), receptor activity-modifying protein 1 (RAMP1), and calcitonin gene-related peptide (CGRP) immunoreactivity in the rat trigeminovascular system: differences between peripheral and central CGRP receptor distribution.
Lennerz JK; Rühle V; Ceppa EP; Neuhuber WL; Bunnett NW; Grady EF; Messlinger K
J Comp Neurol; 2008 Mar; 507(3):1277-99. PubMed ID: 18186028
[TBL] [Abstract][Full Text] [Related]
14. Is there an inherent limit to the efficacy of calcitonin gene-related peptide receptor antagonists in the acute treatment of migraine? A comment.
Tfelt-Hansen PC
J Headache Pain; 2009 Dec; 10(6):389-91. PubMed ID: 19779958
[TBL] [Abstract][Full Text] [Related]
15. Determinants of 1-piperidinecarboxamide, N-[2-[[5-amino-l-[[4-(4-pyridinyl)-l-piperazinyl]carbonyl]pentyl]amino]-1-[(3,5-dibromo-4-hydroxyphenyl)methyl]-2-oxoethyl]-4-(1,4-dihydro-2-oxo-3(2H)-quinazolinyl) (BIBN4096BS) affinity for calcitonin gene-related peptide and amylin receptors--the role of receptor activity modifying protein 1.
Hay DL; Christopoulos G; Christopoulos A; Sexton PM
Mol Pharmacol; 2006 Dec; 70(6):1984-91. PubMed ID: 16959943
[TBL] [Abstract][Full Text] [Related]
16. Receptor activity-modifying protein 1 determines the species selectivity of non-peptide CGRP receptor antagonists.
Mallee JJ; Salvatore CA; LeBourdelles B; Oliver KR; Longmore J; Koblan KS; Kane SA
J Biol Chem; 2002 Apr; 277(16):14294-8. PubMed ID: 11847213
[TBL] [Abstract][Full Text] [Related]
17. Localization of calcitonin receptor-like receptor and receptor activity modifying protein 1 in enteric neurons, dorsal root ganglia, and the spinal cord of the rat.
Cottrell GS; Roosterman D; Marvizon JC; Song B; Wick E; Pikios S; Wong H; Berthelier C; Tang Y; Sternini C; Bunnett NW; Grady EF
J Comp Neurol; 2005 Sep; 490(3):239-55. PubMed ID: 16082677
[TBL] [Abstract][Full Text] [Related]
18. Cerebellar distribution of calcitonin gene-related peptide (CGRP) and its receptor components calcitonin receptor-like receptor (CLR) and receptor activity modifying protein 1 (RAMP1) in rat.
Edvinsson L; Eftekhari S; Salvatore CA; Warfvinge K
Mol Cell Neurosci; 2011 Jan; 46(1):333-9. PubMed ID: 21040789
[TBL] [Abstract][Full Text] [Related]
19. CGRP receptor activity in mice with global expression of human receptor activity modifying protein 1.
Bohn KJ; Li B; Huang X; Mason BN; Wattiez AS; Kuburas A; Walker CS; Yang P; Yu J; Heinz BA; Johnson KW; Russo AF
Br J Pharmacol; 2017 Jun; 174(12):1826-1840. PubMed ID: 28317098
[TBL] [Abstract][Full Text] [Related]
20. Targeting a family B GPCR/RAMP receptor complex: CGRP receptor antagonists and migraine.
Moore EL; Salvatore CA
Br J Pharmacol; 2012 May; 166(1):66-78. PubMed ID: 21871019
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
